Mark A. Eiteman, PhD

Dr. Eiteman's laboratory is developing microbial processes to generate fuels and chemicals. Through an understanding of microbial regulatory mechanisms and redox balance constraints, strains and processes are developed to maximize product formation. Examples of products of recent interest include succinic acid, lactic acid, pyruvic acid and 5-aminolevulinate. Additionally, they are developing technology to remove the microbial growth inhibitor acetic acid selectively from lignocellulosic hydrolysates, and to convert the resulting mixed sugar stream into ethanol.

Part of The Investigator's Annexe program.

Mark A. Eiteman, PhD

Mark A. Eiteman, PhD, University of Georgia

Products

E. coli Strain ALS1038

E. coli Strain ALS1048

E. coli Strain ALS1054

E. coli Strain ALS1058

E. coli Strain ALS1059

E. coli Strain ALS1060

E. coli Strain ALS1073

E. coli Strain ALS1074

E. coli Strain ALS1122

E. coli Strain ALS1370

E. coli Strain ALS1371

E. coli Strain ALS1391

E. coli Strain ALS1392

E. coli Strain ALS929

E. coli Strain ALS974